Plavix
Product Images NDC 16590-288

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Plavix (NDC 16590-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart Image (Plavix 75mg Chart)

A line graph comparing the cumulative event rate (%) of fatal or non-fatal vascular events over months of follow-up between PLAVIX and aspirin. The x-axis represents 0 to 36 months of follow-up, and the y-axis shows the cumulative event rate up to 16%. Two lines illustrate event rates for PLAVIX and aspirin, with a reported P value of 0.045.*

FDA Label Image

Chart Image 2 (Plavix 75mg Chart2)

A line graph showing cumulative event rates (%) of cardiovascular death, myocardial infarction, and stroke over 12 months of follow-up. Two curves compare PLAVIX (+ aspirin) versus placebo (+ aspirin), with PLAVIX showing a lower cumulative event rate. The graph includes a p-value of 0.00009 indicating statistical significance.*

FDA Label Image

Chart Image3 (Plavix 75mg Chart3)

A Kaplan-Meier survival curve showing the percentage of deaths before first discharge over 28 days since randomization. The graph compares two groups, one treated with placebo and the other with clopidogrel, indicating death counts and proportional risk reduction for clopidogrel versus placebo.*

FDA Label Image

Label Image (Plavix 75mg Label)

PLAVIX 75 mg tablet bottle label from STAT RX USA LLC, containing 30 tablets. The label identifies Plavix as generic for clopidogrel bisulfate equivalent to 75 mg clopidogrel base, includes the NDC 16590-288-30, and lists the manufacturer as Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Warnings about possible side effects such as headaches, nausea, dizziness, diarrhea, and stomach pains are also visible.*

FDA Label Image

Structure Image (Plavix 75mg Structure)

Chemical structure of the active ingredient in PLAVIX showing a thienopyridine core with a chlorophenyl group, a methoxycarbonyl moiety, and a sulfate (H2SO4) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.